<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35454174</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2218-273X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>16</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biomolecules</Title>
          <ISOAbbreviation>Biomolecules</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">585</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/biom12040585</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">ANGPTL3 stimulates lipolysis in adipocytes, but the underlying molecular mechanism is yet unknown. The C-terminal fibrinogen-like domain of ANGPTL3 (ANGPTL3-Fld) activates the AKT pathway in endothelial cells. Hence, we evaluated whether ANGPTL3-Fld stimulates lipolysis in adipocytes through the MAPK kinase pathway.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS">3T3-L1 adipocytes were treated with isoproterenol (ISO), ANGPTL3-Fld, or both. Lipolysis was evaluated through the release of free fatty acids (FFAs) in the culture medium. The activation status of intracellular kinases was evaluated with and without the inhibition of the BRAF-ERK arm of the MAPK pathway.</AbstractText>
          <AbstractText Label="RESULTS">ANGPTL3-Fld alone was not able to activate lipolysis, while the combination of ANGPTL3-Fld and ISO determined a 10-fold enrichment of the FFA concentration in the culture medium with an incremental effect (twofold) when compared with ISO alone. ANGPTL3-Fld alone inhibited hormone-sensitive lipase (HSL), whereas the treatment with ISO induced the activation of HSL. The net balance of ANGPTL3-Fld and ISO cotreatment resulted in HSL activation. The results indicate that ANGPTL3-Fld generated an intracellular activation signal involving the MAPK-ERK pathway, possibly through the PDGFRβ-PLCγ-AMPK axis.</AbstractText>
          <AbstractText Label="CONCLUSION">ANGPTL3-Fld appears to act as a facilitator of lipolysis in adipocytes, and this effect was driven by a signal mediated by a pathway that is different from the canonical β-adrenergic stimulus.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bini</LastName>
            <ForeName>Simone</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-1006-4636</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pecce</LastName>
            <ForeName>Valeria</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Costanzo</LastName>
            <ForeName>Alessia</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Polito</LastName>
            <ForeName>Luca</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghadiri</LastName>
            <ForeName>Ameneh</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Minicocci</LastName>
            <ForeName>Ilenia</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tambaro</LastName>
            <ForeName>Federica</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0001-8863-3459</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Covino</LastName>
            <ForeName>Stella</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arca</LastName>
            <ForeName>Marcello</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>D'Erasmo</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0002-9174-4667</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, viale dell'Università n. 37, 00161 Rome, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Biomolecules</MedlineTA>
        <NlmUniqueID>101596414</NlmUniqueID>
        <ISSNLinking>2218-273X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000091303">Angiopoietin-Like Protein 3</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C404495">Angptl3 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005230">Fatty Acids, Nonesterified</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9001-32-5</RegistryNumber>
          <NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.1.13</RegistryNumber>
          <NameOfSubstance UI="D002787">Sterol Esterase</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>L628TT009W</RegistryNumber>
          <NameOfSubstance UI="D007545">Isoproterenol</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D041721" MajorTopicYN="N">3T3-L1 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000091303" MajorTopicYN="Y">Angiopoietin-Like Protein 3</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005230" MajorTopicYN="N">Fatty Acids, Nonesterified</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005340" MajorTopicYN="N">Fibrinogen</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007545" MajorTopicYN="N">Isoproterenol</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008066" MajorTopicYN="Y">Lipolysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="Y">MAP Kinase Signaling System</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002787" MajorTopicYN="N">Sterol Esterase</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">ANGPTL3</Keyword>
        <Keyword MajorTopicYN="Y">ERK pathway</Keyword>
        <Keyword MajorTopicYN="Y">adipose tissue</Keyword>
        <Keyword MajorTopicYN="Y">fibrinogen-like domain</Keyword>
        <Keyword MajorTopicYN="Y">lipid metabolism</Keyword>
        <Keyword MajorTopicYN="Y">lipolysis</Keyword>
      </KeywordList>
      <CoiStatement>No specific conflict of interest exist for the present study. LD has received personal fees for public speaking, consultancy or grant support from Amryt Pharmaceuticals, Akcea Therapeutics, Pfizer, Amgen and Sanofi; MA has received research grant support from Amryt Pharmaceutical, Amgen, IONIS, Akcea Therapeutics, Pfizer and Sanofi; has served as a consultant for Amgen, Aegerion, Akcea Therapeutics, Regeneron, Sanofi and Alfasigma and received lecturing fees from Amgen, Amryt Pharmaceuticals, Pfizer, Sanofi and AlfaSigma.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>1</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35454174</ArticleId>
        <ArticleId IdType="pmc">PMC9028860</ArticleId>
        <ArticleId IdType="doi">10.3390/biom12040585</ArticleId>
        <ArticleId IdType="pii">biom12040585</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bini S., D’erasmo L., Di Costanzo A., Minicocci I., Pecce V., Arca M. The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases? Int. J. Mol. Sci. 2021;22:742.  doi: 10.3390/ijms22020742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22020742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang R., Zhang K. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues. Prog. Lipid Res. 2021;85:101140. doi: 10.1016/j.plipres.2021.101140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.plipres.2021.101140</ArticleId>
            <ArticleId IdType="pmc">PMC8760165</ArticleId>
            <ArticleId IdType="pubmed">34793860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koishi R., Ando Y., Ono M., Shimamura M., Yasumo H., Fujiwara T., Horikoshi H., Furukawa H. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 2002;30:151–157. doi: 10.1038/ng814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng814</ArticleId>
            <ArticleId IdType="pubmed">11788823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arca M., D’Erasmo L., Minicocci I. Familial combined hypolipidemia: Angiopoietin-like protein-3 deficiency. Curr. Opin. Lipidol. 2020;31:41–48. doi: 10.1097/MOL.0000000000000668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MOL.0000000000000668</ArticleId>
            <ArticleId IdType="pubmed">32022755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robciuc M.R., Maranghi M., Lahikainen A., Rader D., Bensadoun A., Öörni K., Metso J., Minicocci I., Ciociola E., Ceci F., et al.  Angptl3 Deficiency Is Associated With Increased Insulin Sensitivity, Lipoprotein Lipase Activity, and Decreased Serum Free Fatty Acids. Arter. Thromb. Vasc. Biol. 2013;33:1706–1713. doi: 10.1161/ATVBAHA.113.301397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.113.301397</ArticleId>
            <ArticleId IdType="pubmed">23661675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ono M., Shimizugawa T., Shimamura M., Yoshida K., Noji-Sakikawa C., Ando Y., Koishi R., Furukawa H. Protein Region Important for Regulation of Lipid Metabolism in Angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J. Biol. Chem. 2003;278:41804–41809. doi: 10.1074/jbc.M302861200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M302861200</ArticleId>
            <ArticleId IdType="pubmed">12909640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tikkanen E., Minicocci I., Hällfors J., Di Costanzo A., D’Erasmo L., Poggiogalle E., Donini L.M., Würtz P., Jauhiainen M., Olkkonen V.M., et al.  Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State. Arter. Thromb. Vasc. Biol. 2019;39:665–674. doi: 10.1161/ATVBAHA.118.312021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.118.312021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Minicocci I., Tikka A., Poggiogalle E., Metso J., Montali A., Ceci F., Labbadia G., Fontana M., Di Costanzo A., Maranghi M., et al.  Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism. J. Lipid Res. 2016;57:1097–1107. doi: 10.1194/jlr.P066183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1194/jlr.P066183</ArticleId>
            <ArticleId IdType="pmc">PMC4878193</ArticleId>
            <ArticleId IdType="pubmed">27040449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camenisch G., Pisabarro M.T., Sherman D., Kowalski J., Nagel M., Hass P., Xie M.-H., Gurney A., Bodary S., Liang X.H., et al.  ANGPTL3 Stimulates Endothelial Cell Adhesion and Migration via Integrin αvβ3 and Induces Blood Vessel Formation in Vivo. J. Biol. Chem. 2002;277:17281–17290. doi: 10.1074/jbc.M109768200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M109768200</ArticleId>
            <ArticleId IdType="pubmed">11877390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maik-Rachline G., Wortzel I., Seger R. Alternative Splicing of MAPKs in the Regulation of Signaling Specificity. Cells. 2021;10:3466.  doi: 10.3390/cells10123466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells10123466</ArticleId>
            <ArticleId IdType="pmc">PMC8699841</ArticleId>
            <ArticleId IdType="pubmed">34943973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei Z., Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12:9–18. doi: 10.1038/sj.cr.7290105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.cr.7290105</ArticleId>
            <ArticleId IdType="pubmed">11942415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watt M.J., Holmes A.G., Pinnamaneni S.K., Garnham A.P., Steinberg G., Kemp B., Febbraio M.A. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol. Metab. 2006;290:E500–E508. doi: 10.1152/ajpendo.00361.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00361.2005</ArticleId>
            <ArticleId IdType="pubmed">16188906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vemurafenib Datasheet [Internet]  [(accessed on 13 April 2022)].  Available online:  https://www.selleckchem.com/products/PLX-4032.</Citation>
        </Reference>
        <Reference>
          <Citation>Brasaemle D.L., Levin D.M., Adler-Wailes D.C., Londos C. The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets. Biochim. Biophys. Acta (BBA)—Mol. Cell Biol. Lipids. 2000;1483:251–262. doi: 10.1016/S1388-1981(99)00179-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1388-1981(99)00179-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pecce V., Verrienti A., Abballe L., Carletti R., Grani G., Falcone R., Ramundo V., Durante C., Di Gioia C., Russo D., et al.  Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid. Cancers. 2020;12:1892.  doi: 10.3390/cancers12071892.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers12071892</ArticleId>
            <ArticleId IdType="pmc">PMC7409075</ArticleId>
            <ArticleId IdType="pubmed">32674319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berndt S., Liebscher I. New Structural Perspectives in G Protein-Coupled Receptor-Mediated Src Family Kinase Activation. Int. J. Mol. Sci. 2021;22:6489.  doi: 10.3390/ijms22126489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22126489</ArticleId>
            <ArticleId IdType="pmc">PMC8233884</ArticleId>
            <ArticleId IdType="pubmed">34204297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valle-Mendiola A., Soto-Cruz I. Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes. Cancers. 2020;12:124.  doi: 10.3390/cancers12010124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers12010124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham R.P., Sheldon R.D., Rector R.S. The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development. Front. Physiol. 2020;11:767. doi: 10.3389/fphys.2020.00767.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphys.2020.00767</ArticleId>
            <ArticleId IdType="pmc">PMC7350778</ArticleId>
            <ArticleId IdType="pubmed">32719616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evseeva M.N., Balashova M.S., Kulebyakin K.Y., Rubtsov Y.P. Adipocyte Biology from the Perspective of In Vivo Research: Review of Key Transcription Factors. Int. J. Mol. Sci. 2021;23:322.  doi: 10.3390/ijms23010322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms23010322</ArticleId>
            <ArticleId IdType="pmc">PMC8745732</ArticleId>
            <ArticleId IdType="pubmed">35008748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin N., Matter W.F., Michael L.F., Qian Y., Gheyi T., Cano L., Perez C., Lafuente C., Broughton H.B., Espada A. The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage. ACS Chem. Biol. 2021;16:457–462. doi: 10.1021/acschembio.0c00954.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acschembio.0c00954</ArticleId>
            <ArticleId IdType="pubmed">33656326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chi X., Britt E.C., Shows H.W., Hjelmaas A.J., Shetty S.K., Cushing E.M., Li W., Dou A., Zhang R., Davies B.S. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase. Mol. Metab. 2017;6:1137–1149. doi: 10.1016/j.molmet.2017.06.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molmet.2017.06.014</ArticleId>
            <ArticleId IdType="pmc">PMC5641604</ArticleId>
            <ArticleId IdType="pubmed">29031715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tošić I., Frank D.A. STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications. Neoplasia. 2021;23:1167–1178. doi: 10.1016/j.neo.2021.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neo.2021.10.003</ArticleId>
            <ArticleId IdType="pmc">PMC8569436</ArticleId>
            <ArticleId IdType="pubmed">34731785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoue H., Ogawa W., Ozaki M., Haga S., Matsumoto M., Furukawa K., Hashimoto N., Kido Y., Mori T., Sakaue H., et al.  Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat. Med. 2004;10:168–174. doi: 10.1038/nm980.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm980</ArticleId>
            <ArticleId IdType="pubmed">14716305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Z., Daquinag A.C., Su F., Snyder B., Kolonin M.G. PDGFRα / PDGFRβ signaling balance modulates progenitor cell differentiation into white and beige adipocytes. Development. 2018;145:dev155861. doi: 10.1242/dev.155861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.155861</ArticleId>
            <ArticleId IdType="pmc">PMC6514402</ArticleId>
            <ArticleId IdType="pubmed">29158445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onogi Y., Wada T., Kamiya C., Inata K., Matsuzawa T., Inaba Y., Kimura K., Inoue H., Yamamoto S., Ishii Y., et al.  PDGFRβ Regulates Adipose Tissue Expansion and Glucose Metabolism via Vascular Remodeling in Diet-Induced Obesity. Diabetes. 2017;66:1008–1021. doi: 10.2337/db16-0881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db16-0881</ArticleId>
            <ArticleId IdType="pubmed">28122789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banfi S., Gusarova V., Gromada J., Cohen J.C., Hobbs H.H. Increased thermogenesis by a noncanonical pathway in ANGPTL3/8-deficient mice. Proc. Natl. Acad. Sci. USA. 2018;115:E1249–1258. doi: 10.1073/pnas.1717420115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1717420115</ArticleId>
            <ArticleId IdType="pmc">PMC5819435</ArticleId>
            <ArticleId IdType="pubmed">29358393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dewey F.E., Gusarova V., Dunbar R., O’dushlaine C., Schurmann C., Gottesman O., McCarthy S., Van Hout C.V., Bruse S., Dansky H.M., et al.  Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease. N. Engl. J. Med. 2017;377:211–221. doi: 10.1056/NEJMoa1612790.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1612790</ArticleId>
            <ArticleId IdType="pmc">PMC5800308</ArticleId>
            <ArticleId IdType="pubmed">28538136</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
